Skip to content
Screener

Hinge Health HNGE D&A

D&A at other companies

Globus Medical logo
Globus MedicalGMED
$69.5M-1.6%
National Research Corporation logo
National Research CorporationNRC
$2.12M+21.8%
LifeMD, Inc. logo
LifeMD, Inc.LFMD
$289.46K+86.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$270.8M-0.4%
Enovis logo
EnovisENOV
$71.03M-0.7%
3D Systems logo
3D SystemsDDD
$5.13M-10.2%

Other financials

Income statement

See full
Revenue$212.8M+53.0%
Gross profit$183.9M+88.2%
Operating income$40.4M+107%
Net income$43.7M+108%
EPS (diluted)$0.52+104%

Balance sheet

See full
Cash & equivalents$287.7M+20.4%
Total debt$5.9M-40.9%
Total equity$344.3M+98.1%
Total assets$827.4M+19.3%

Cash flow

See full
Operating cash flow$101.4M+401%
CapEx$123.0K-37.6%
Free cash flow$101.3M+406%

Valuation

See full
Market cap$6.2B+31.2%
Enterprise value$5.91B+31.6%
P/E80.5×—
P/S8.6×-1.2×

Profitability

See full
Gross margin84.5%+6.8pp
Operating margin9.2%—
Net margin10.7%—
FCF margin40.3%+21.3pp

Returns & leverage

See full
Return on equity29.7%—
Debt / equity0×0.0×
Current ratio1.3×-0.6×

Where this comes from

Reported directly by Hinge Health in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The source filing: Hinge Health’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054327

FAQ

What is Hinge Health's D&A?
Hinge Health (HNGE) reported D&A of $1.06M in Q2 2026.
How has Hinge Health's D&A changed year-over-year?
Hinge Health's D&A decreased by 21.0% year-over-year, from $1.34M to $1.06M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Ask your AI about Hinge Health's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude